Patients from a mesenchymal subtype (derived from immune gene expression subtyping in ovarian cancer) had the lowest tumor purity, a high leukocyte fraction, and a stromal fraction with the highest TGF-β response [47]. This evidence concerns the gene TGFB1 and ovarian carcinoma.